Comparative Profiling of Circulating Exosomal Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary Adenocarcinoma

• Autores: Guio, H, Aliaga-Tobar, V, Galarza, M, Pellon-Cardenas, O, Capristano, S, Gomez-Moreno, HL, Olivera-Hurtado, M, Sanchez, C, Maracaja-Coutinho, V
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Instituto Nacional de Enfermedades Neoplásicas
• Repositorio: INEN-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.inen.sld.pe:20.500.14703/296
• Enlace del recurso: https: //doi.org/10.3389/fcimb.2022.909837; https://hdl.handle.net/20.500.14703/296
• Nivel de acceso: acceso abierto
• Materia: circulating RNAs; exosomes; microRNAs; non-small cell lung cancer; Peruvian; small RNA sequencing; small RNAs; tuberculosis; https://purl.org/pe-repo/ocde/ford#3.02.21

Tuberculosis (TB) is one of the most fatal infectious diseases, caused by the aerobic bacteria Mycobacterium tuberculosis. It is estimated that one-third of the world’s population is infected with the latent (LTB) version of this disease, with only 5-10% of infected individuals developing its active (ATB) form. Pulmonary adenocarcinoma (PA) is the most common and diverse form of primary lung carcinoma. The simultaneous or sequential occurrence of TB and lung cancer in patients has been widely reported and is known to be an issue for diagnosis and surgical treatment. Raising evidence shows that patients cured of TB represent a group at risk for developing PA. In this work, using sRNA-sequencing, we evaluated the expression patterns of circulating small RNAs available in exosomes extracted from blood samples of Peruvian patients affected by latent tuberculosis, active tuberculosis, or pulmonary adenocarcinoma. Differential expression analysis revealed a set of 24 microRNAs perturbed in these diseases, revealing potential biomarker candidates for the Peruvian population. Most of these miRNAs are normally expressed in healthy lung tissue and are potential regulators of different shared and unique KEGG pathways related to cancers, infectious diseases, and immunology. Copyright © 2022 Guio, Aliaga-Tobar, Galarza, Pellon-Cardenas, Capristano, Gomez, Olivera, Sanchez and Maracaja-Coutinho.